The JNK inhibitor XG-102 protects against TNBS-induced colitis.
about
JNK signalling in cancer: in need of new, smarter therapeutic targetsResveratrol modulates cytokine-induced Jak/STAT activation more efficiently than 5-aminosalicylic acid: an in vitro approachDifferential Relevance of NF-κB and JNK in the Pathophysiology of Hemorrhage/Resususcitation-Induced Liver Injury after Chronic Ethanol FeedingXG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study.The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium.Jnk2 deletion disrupts intestinal mucosal homeostasis and maturation by differentially modulating RNA-binding proteins HuR and CUGBP1.Hyperthermia differently affects connexin43 expression and gap junction permeability in skeletal myoblasts and HeLa cells.Gadolinium chloride improves the course of TNBS and DSS-induced colitis through protecting against colonic mucosal inflammationModulation of c-Jun N-terminal kinase signaling and specific glucocorticoid receptor phosphorylation in the treatment of major depression.Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretionTEC and MAPK Kinase Signalling Pathways in T helper (TH) cell Development, TH2 Differentiation and Allergic Asthma.JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.JNK inhibitors as anti-inflammatory and neuroprotective agents.Repeated H2 O2 exposure drives cell cycle progression in an in vitro model of ulcerative colitis.The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders.Investigation of the relationship between the Th17/IL-23 pathway and innate-adaptive immune system in TNBS-induced colitis in rats.Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.Local level of TGF-β1 determines the effectiveness of dexamethasone through regulating the balance of Treg/Th17 cells in TNBS-induced mouse colitis.Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis.c-Jun N-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine.
P2860
Q27023869-1D908BA8-586C-4BC2-B8F7-D91C34E7D614Q28543472-94C0C127-4BE9-49E7-9B8E-E35C744A6EF6Q30402748-84338A40-0FAB-4B9A-86D8-F44E62070E10Q30423728-D02754D3-19E9-4555-97B8-6C852127DC49Q30454726-9D7A5331-1D5C-4C59-889C-9E1AFF4958C4Q33764707-33243CD0-51D9-4BA6-8897-B01CC2AE8F2AQ34038093-EB482AE6-32A2-4DCB-BBFA-8F72B8D46A30Q34077080-E135AE33-5081-4164-8FDC-6B24BD976D0DQ35995461-53793768-09D2-4CC3-88A9-C41069D12B4AQ36156368-92EAB443-2161-4C54-813F-50F0D7F15B96Q37219806-75B53D1C-6798-466F-AAE6-43F2698EC49AQ37705086-0ED0B3EC-FBCA-42BE-B108-B4182444CA53Q38097866-27A83530-D4BE-481D-80C8-E891CF8176B3Q39080578-BD09415A-BEE9-4154-832C-D3933A892399Q42253045-66067F31-244A-41CD-915F-7D5E1824B0E9Q47108861-AC633FFC-7EF3-4843-8239-F06BBB4707D6Q50662194-D1BF1652-8ACD-45AE-8337-275AFF93DBFDQ51653926-6553C035-A7F1-4A69-BF0A-B435878735B3Q51739512-BEC5D3A1-A3DE-4ED6-983A-F79F93D2B31AQ51825944-41B9E17C-F3B7-40FD-891D-4BF100517AC0Q55005402-84B55F71-96A3-4334-AA0B-F47AB338F829
P2860
The JNK inhibitor XG-102 protects against TNBS-induced colitis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The JNK inhibitor XG-102 protects against TNBS-induced colitis
@nl
The JNK inhibitor XG-102 protects against TNBS-induced colitis.
@ast
The JNK inhibitor XG-102 protects against TNBS-induced colitis.
@en
type
label
The JNK inhibitor XG-102 protects against TNBS-induced colitis
@nl
The JNK inhibitor XG-102 protects against TNBS-induced colitis.
@ast
The JNK inhibitor XG-102 protects against TNBS-induced colitis.
@en
prefLabel
The JNK inhibitor XG-102 protects against TNBS-induced colitis
@nl
The JNK inhibitor XG-102 protects against TNBS-induced colitis.
@ast
The JNK inhibitor XG-102 protects against TNBS-induced colitis.
@en
P2093
P2860
P1433
P1476
The JNK inhibitor XG-102 protects against TNBS-induced colitis.
@en
P2093
Ale Laukevicience
Ansgar Michael Chromik
Christian Sina
Franziska Dierck
Ivo Leuschner
Kirstin Reinecke
Olga Gavrilova
Sabine Kersting
Sevgi Eminel
Thomas Herdegen
P2860
P304
P356
10.1371/JOURNAL.PONE.0030985
P407
P577
2012-03-13T00:00:00Z